Jessalyn J Baljon

Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for bone tissue engineering

Benjamin M. Wu, Min Lee, Jessalyn J. Baljon, 2019, Nature Communications.

A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of antigen and PolyIC RNA.

John T. Wilson, Jessalyn J. Baljon, Lihong Wang-Bishop, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Co-Delivery of Peptide Neoantigens and Stimulator of Interferon Genes (STING) Agonists Enhances Response to Cancer Vaccines.

John T. Wilson, Jessalyn J. Baljon, M. Wehbe, 2020, ACS nano.

Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.

John T. Wilson, Jessalyn J. Baljon, Sema Sevimli, 2018, Biomaterials.

At the bench: Engineering the next generation of cancer vaccines

John T. Wilson, Jessalyn J. Baljon, M. Wehbe, 2019, Journal of leukocyte biology.

Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.

J. Balko, K. Boyd, John T. Wilson, 2020, Journal of controlled release : official journal of the Controlled Release Society.

The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome.

John T. Wilson, Jessalyn J. Baljon, Aamina Dandy, 2019, Biomaterials science.

Bioinspired vaccines to enhance MHC class-I antigen cross-presentation.

John T. Wilson, Jessalyn J. Baljon, Jessalyn J Baljon, 2022, Current opinion in immunology.

Flash nanoprecipitation for the production of endosomolytic polymersomes for cytosolic drug delivery

John T. Wilson, Jessalyn J. Baljon, L. Pastora, 2021 .